1. Home
  2. CAR vs KNSA Comparison

CAR vs KNSA Comparison

Compare CAR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

HOLD

Current Price

$303.24

Market Cap

3.4B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$47.04

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAR
KNSA
Founded
1946
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
CAR
KNSA
Price
$303.24
$47.04
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$127.57
$55.29
AVG Volume (30 Days)
1.8M
565.9K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
50.71
225.00
EPS
N/A
0.75
Revenue
$11,652,000,000.00
$677,564,000.00
Revenue This Year
$2.17
$38.01
Revenue Next Year
$1.78
$17.42
P/E Ratio
N/A
$63.27
Revenue Growth
N/A
60.09
52 Week Low
$66.79
$19.42
52 Week High
$297.53
$50.03

Technical Indicators

Market Signals
Indicator
CAR
KNSA
Relative Strength Index (RSI) 91.65 51.17
Support Level $138.94 $39.96
Resistance Level N/A $48.14
Average True Range (ATR) 26.83 1.83
MACD 17.94 -0.03
Stochastic Oscillator 93.95 45.20

Price Performance

Historical Comparison
CAR
KNSA

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: